BIOCRYST PHARMACEUTICALS INC (BCRX) Stock Cash Flow
NASDAQ:BCRX - Nasdaq - US09058V1035 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -53.47M | -88.88M | -226.54M | -247.12M | -184.06M | |||
| Depreciation Amortization | 1.27M | 1.25M | 1.66M | 1.44M | 780.00K | |||
| Change In Working Capital | -100.89M | -87.28M | -32.40M | -58.95M | 8.12M | |||
| Interest Paid | 34.55M | 30.38M | 22.14M | N/A | N/A | |||
| Taxes Paid | 1.42M | 1.60M | 1.43M | N/A | N/A | |||
| Other non cash items | 127.24M | 122.90M | 162.14M | 142.77M | 33.00M | |||
| OPERATING CASH FLOW | -25.85M | -52.02M | -95.14M | -161.85M | -142.16M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.03M | -1.12M | -2.17M | -1.35M | -2.39M | |||
| Other Investing Activity | 51.96M | 53.72M | -129.33M | -126.89M | 18.19M | |||
| INVESTING CASH FLOW | 50.93M | 52.59M | -131.50M | -128.24M | 15.80M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -1.83M | -1.70M | 58.38M | 73.07M | 293.87M | |||
| Stock Issued/Repurchased | 4.18M | 3.48M | 8.68M | 14.96M | 65.79M | |||
| Other Financing Activity | -6.54M | -7.54M | -34.58M | N/A | N/A | |||
| FINANCING CASH FLOW | -4.18M | -5.76M | 32.48M | 88.03M | 359.67M | |||
| Exchange Rate Effect | -145.00K | -936.00K | 362.00K | 570.00K | 70.00K | |||
| CHANGE IN CASH | 20.75M | -6.12M | -193.79M | -201.49M | 233.38M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -25.85M | -52.02M | -95.14M | -161.85M | -142.16M | |||
| Capital Expenditure | -1.03M | -1.12M | -2.17M | -1.35M | -2.39M | |||
| FREE CASH FLOW | -26.89M | -53.14M | -97.31M | -163.20M | -144.55M | |||
All data in USD